drugset / Trial / NCT00048932
A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this clinical research study is to learn if abatacept is safe when co-administered with other approved rheumatoid arthritis medications.
Timeline
- Start
- 2002-12
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Abatacept | Other / unclassified | 500 mg | Intravenous |
| Comparator | Abatacept | Other / unclassified | 750 mg | Intravenous |
| Comparator | Abatacept | Other / unclassified | 1000 mg | Intravenous |